Objective: To investigate the relationship between preoperative atrial fibrillation and early and late clinical outcomes following cardiac surgery. Methods: A retrospective cohort including all consecutive coronary artery bypass graft and/or valve surgery patients between 1995 and 2005 was identified (n = 9796). No patient had a concomitant surgical AF ablation. The association between preoperative atrial fibrillation and inhospital outcomes was examined. We also determined late death and cardiovascular-related re-hospitalization by linking to administrative health databases. Median follow-up was 2.9 years (maximum 11 years). Results: The prevalence of preoperative atrial fibrillation was 11.3% (n = 1105), ranging from 7.2% in isolated CABG to 30% in valve surgery. In-hospital mortality, stroke, and renal failure were more common in atrial fibrillation patients (all p < 0.0001), although the association between atrial fibrillation and mortality was not statistically significant in multivariate logistic regression. Longitudinal analyses showed that preoperative atrial fibrillation was associated with decreased event-free survival (adjusted hazard ratio 1.55, 95% confidence interval 1.42-1.70, p < 0.0001). Conclusions: Preoperative atrial fibrillation is associated with increased late mortality and recurrent cardiovascular events post-cardiac surgery. Effective management strategies for atrial fibrillation need to be explored and may provide an opportunity to improve the long-term outcomes of cardiac surgical patients. #
Introduction
Atrial fibrillation (AF) is the most common dysrhythmia encountered in clinical practice, with an overall prevalence in the general population of 0.4-1% [1] . The prevalence of AF is tightly linked to age and may reach almost 10% in those aged 80 years and above [1] . AF has prognostic importance and is associated with a two-fold increase in the risk of mortality and a two-to-six-fold increase in the risk of stroke when compared to subjects in normal sinus rhythm [2] . Recently it was shown that survival was similar among lone AF patients without demonstrable cardiovascular pathology and age-and sex-matched controls without AF [3] . These results suggest that the association between AF and cardiovascular events appears to be dependent on the presence of underlying structural heart disease. However, published evidence from the cardiac surgical literature is conflicting and the independent influence of pre-existing AF on the clinical outcomes of patients following surgical coronary revascularization and/or valve repair or replacement is unclear [4] [5] [6] . Therefore, the objective of this study was to examine the relationship between pre-existing, preoperative AF on early and late clinical outcomes in a large, contemporary cohort of cardiac surgery patients.
Material and methods

Study subjects
A retrospective cohort design was used. All consecutive adult patients undergoing coronary artery bypass graft surgery (CABG) and/or valve repair or replacement surgery at our institution between March 1995 and September 2005 were identified. No patient had a concomitant surgical AF ablation. Patient demographics, baseline clinical characteristics including cardiovascular and non-cardiovascular comorbid illnesses, as well as intra-and postoperative (inhospital) data were provided by our local institutional clinical registry. The registry contains prospectively collected information on more than 200 variables that is entered into a computerized database at the time of surgery. Its accuracy has previously been shown [7] . Variable definitions are consistent with the Society of Thoracic Surgeons' widely published and accepted standards [8] . Preoperative AF was defined as AF present on 12-lead electrocardiogram or rhythm monitor prior to cardiac surgery or a history of AF documented in the medical record for which the patient required treatment or hospital admission, irrespective of the duration of the AF or actual rhythm prior to cardiac surgery. The distribution of demographic, clinical, and operative variables was compared among patients with preoperative AF and those without AF.
In-hospital adverse events
The in-hospital outcomes of interest were: death, dependence on a mechanical ventilator for a period exceeding 24 h, stroke, the insertion of an intra-aortic balloon pump (IABP) during surgery or during the postoperative period, new-onset postoperative renal failure, deep sternal wound infection, and length of hospitalization from the time of operation to hospital discharge. Stroke was defined as a new, permanent neurologic deficit following surgery accompanied by an acute structural change on intracranial computed tomography or magnetic resonance imaging. Subtle cognitive changes, delirium, and reversible deficits were not included in the stroke endpoint. Renal failure was defined as a 30% or greater increase in the baseline serum creatinine value or a new, postoperative requirement for renal dialysis therapy either temporarily or on a permanent basis. Deep sternal wound infection was defined as the occurrence of acute mediastinitis in a patient with corroborative findings such as systemic signs of infection, purulent drainage from the sternum, and sternal dehiscence requiring surgical exploration and debridement. Superficial sternal and wound infections involving the graft conduit harvest site(s) were not included in the end-point. Individual outcomes were univariately compared among patients with and without pre-existing AF.
In-hospital mortality was modeled as the dependent variable in a multivariate regression analysis. Demographic, clinical, and operative variables demonstrating a univariate association with in-hospital mortality at a p < 0.10 were presented to the model and a stepwise selection routine was performed in addition to forcing the preoperative AF variable into the model. Interaction terms were also evaluated. Effect estimates were described using odds ratios (ORs) and their associated 95% confidence intervals (CIs). Model discriminatory capacity and calibration were assessed by computing the area under the receiver operating characteristic curve and by using the Hosmer-Lemeshow goodness-of-fit test, respectively [9] . The concordance statistics (c-statistics) of each of the logistic regression models of 200 bootstrap sub-samples were used to compute a 95% CI for the area under the receiver operating characteristic curve [10] .
Late outcomes
The long-term survival and freedom from adverse cardiovascular events were determined for patients that were discharged alive following cardiac surgery. Patients were linked to government administrative health service utilization databases compiled by the Canadian Institute for Health Information and made available by the Population Health Research Unit of Dalhousie University. All-cause mortality was determined by linking to provincial vital statistics. The clinical end-point of interest in this study was the freedom from a composite of all-cause mortality and a first re-admission to hospital due to a cardiovascular cause: acute coronary syndrome, congestive heart failure (CHF), AF, stroke and/or transient ischemic attack, or a primary or repeat coronary revascularization procedure, either percutaneous or surgical. Diagnoses and procedures were identified based on the International Statistical Classification of Diseases and Related Health Problems (ICD) system, revisions 9 and 10. The diagnostic and coding accuracy of administrative health care data has previously been validated [11] .
The freedom from death and cardiovascular re-hospitalization was analyzed using Kaplan-Meier methodology [12] . The association between preoperative AF and the composite outcome was determined by fitting a multivariate Cox proportional hazards regression model, risk-adjusted for comorbidities, operative variables, time period of surgery, and discontinuous intervals of health insurance coverage [13] . The proportionality assumption of the Cox model was assessed using tests of proportionality and Schoenfeld residuals [13] . Risk-adjusted survival curves were generated using the corrected group prognosis method, which has been shown to be methodologically superior to alternative methods for plotting adjusted survival curves [14] . The effect of AF on late outcomes was also assessed across prespecified sub-groups of age, sex, type and time period of surgery, and left ventricular ejection fraction (LVEF). Effect estimates were described using hazard ratios (HRs) and their associated 95% CIs.
Statistical analysis
Statistical analysis for the study was performed using Statistical Analysis System (SAS) software version 8.2 (SAS Institute, Cary, North Carolina). Continuous variables were compared using unpaired t tests or non-parametric equivalents where appropriate. Proportions were compared using chi-square tests or Fisher's exact test where appropriate and Mantel-Haenszel chi-square statistics with one degree of freedom were used to test for trends within ordered categorical variables. Comparisons were considered statistically significant at a p value <0.05 and all p values were two-sided.
Ethical approval
The study protocol was in accordance with the standards of our local institutional research ethics board and those of the Population Health Research Unit at Dalhousie University and has received full ethical approval from each of these bodies.
Results
Baseline characteristics
Between 1995 and 2005, there were 9796 patients that underwent CABG, valve surgery, or a combination of the two procedures at our institution. The overall prevalence of preoperative AF was 11.3% (n = 1105), ranging from 7.2% in isolated CABG to 30.2% in isolated valve surgery. Patients with preoperative AF were more likely to be older, female, and have a greater degree of certain cardiovascular and noncardiovascular comorbid illnesses (Table 1) . Preoperative AF was associated with a greater acuity of operative intervention (Table 2) . Moreover, patients with pre-existing AF undergoing CABG tended to receive fewer grafts, had a decreased rate of utilization of arterial conduit, and had lower rates of off-pump revascularization.
In-hospital adverse events
The incidence of early (in-hospital) mortality for the entire cohort of study participants was 3.1% (n = 303). In crude analysis, preoperative AF was associated with greater than a two-fold increase in in-hospital mortality (6.5% vs 2.7%, p < 0.0001). In addition, the incidence of all of the inhospital end-points examined was significantly increased in patients with preoperative AF (all p < 0.0001), except for deep sternal wound infection, which was equivalent in the 2 groups (Table 3 ). The duration of hospitalization following surgery among survivors to hospital discharge was prolonged in patients with AF (median 8 days vs 7 days, p < 0.0001).
In order to adjust for the baseline disparities in risk between the two comparison groups and to account for variables that may be confounding the observed association between AF and in-hospital mortality, a multivariate logistic regression model was fit. In this model, there was no independent association between preoperative AF and inhospital mortality (adjusted OR 1.28, 95% CI 0.95-1.74, 
Longitudinal analysis
Of the 9493 patients surviving to hospital discharge, 9482 had a valid health card number and were linked to health care databases in order to determine late death and cardiovascular-related re-admissions to hospital. The clinical end-point of interest in the longitudinal analysis was the freedom from a composite of death from any cause and rehospitalization for acute coronary syndromes, CHF, AF, stroke and/or transient ischemic attack, and coronary revascularization. Median follow-up until event or censor was 2.9 years (interquartile range, 0.9-5.6 years, maximum 11 years). There were 4369 events during the study period (46.1%). In unadjusted analysis, the Kaplan-Meier event-free survival of patients with preoperative AF was significantly worse than patients without AF at 1, 3, and 5 years postoperatively: 59%, 43%, and 34% (AF patients) versus 80%, 68%, and 58% (no AF patients), respectively (log-rank p < 0.0001).
A time-to-first-event Cox proportional hazards regression model risk-adjusted for patient demographics, cardiovascular and non-cardiovascular diseases, operative variables, time period of surgery, and discontinuous health insurance coverage was fit. Preoperative AF was associated with a 55% increase in the risk of late death or cardiovascular-related readmission to hospital (adjusted HR 1.55, 95% CI 1.42-1.70, p < 0.0001). The covariates that remained in the model after a stepwise selection procedure are shown in Table 5 . Assessment of the Cox model using tests of proportionality and Schoenfeld residuals revealed that the effects of the predictor variables were the same at all values of time suggesting that the proportionality assumption of the model was not violated. Crude Kaplan-Meier and adjusted eventfree survival curves for the AF and no-AF patient sub-groups are shown in Fig. 1 .
Patients with preoperative AF were further sub-divided into two groups depending on rhythm at discharge and a separate proportional hazards regression analysis was performed. When compared to patients without preoperative AF (referent group with a theoretical HR of 1.0), patients with preoperative AF discharged in AF had the poorest eventfree survival: adjusted HR 1.75, 95% CI 1.56-1.96, p < 0.0001 for patients discharged in AF; adjusted HR 1.39, 95% CI 1.23-1.56, p < 0.0001 for patients discharged in sinus rhythm.
The effect of AF on the freedom from late death and cardiovascular events was determined within pre-specified patient sub-groups using stratified proportional hazards models. No significant differences with respect to the relationship between AF and clinical outcomes were observed across strata of age, sex, and type as well as time period or surgery. However, the magnitude of the effect of AF on long-term outcomes varied significantly according to LVEF, such that AF was associated with an 80% greater risk of death or cardiovascular-related re-hospitalization in patients with a LVEF !40% compared to an 18% increased risk in patients with LVEF <40% ( p interaction <0.05) (Fig. 2) . In the subgroup of patients who received one or more mechanical prosthetic valves (n = 298), pre-existing AF was significantly associated with the composite end-point of late death or re-hospitalization (adjusted HR 1.57, 95% CI 1.10-2.24, p = 0.01).
The components of the composite end-point were also examined individually (Table 6) . Following risk adjustment, AF was significantly associated with increased mortality from any cause (adjusted HR 1.54, 95% CI 1.35-1.75, p < 0.0001). AF also predicted higher rates of admission to hospital for AF, stroke and/or transient ischemic attack, and CHF (all p < 0.0001). However, preoperative AF was not independently associated with subsequent admission to hospital for acute coronary syndrome or coronary revascularization.
Discussion
Several findings in this study are noteworthy. First, in a contemporary cohort of patients who have undergone surgery for coronary artery and/or valvular disease, preexisting AF was an important determinant of late death and cardiovascular-related re-hospitalization, after risk-adjusting for pre-and perioperative variables that are known to affect prognosis following cardiac surgery. The greater rehospitalization rate observed among the AF patients appears to be driven by subsequent admission to hospital for AF, CHF, and cerebrovascular events, but not for cardiac ischemic Fig. 1 . Event-free survival of patients with preoperative atrial fibrillation. Complete lines represent the unadjusted Kaplan-Meier survival curves; adjusted survival curves using the corrected group prognosis method are shown by the broken lines. Fig. 2 . The relationship between preoperative atrial fibrillation and the composite outcome of late death or cardiovascular re-hospitalization across pre-specified patient sub-groups. a p interaction <0.05 (all other interactions were not statistically significant). Table 6 Relationship between preoperative atrial fibrillation and the individual components of the composite end-point.
Outcome
Events events including unstable angina, ST-and non-ST-segment elevation MI, and coronary revascularization procedures, all of which were equivalent among AF and non-AF patients. These findings are consistent with previously published reports demonstrating a relationship between AF and heart failure as well as stroke [15] [16] [17] . Also, AF has been associated with depressed endothelial function and reduced myocardial perfusion, conditions that theoretically predispose to an enhanced ischemic burden [18] . However, we were not able to demonstrate an association between AF and subsequent readmission for cardiac ischemic events in our study. This lack of association may be a consequence of the fact that all study participants with obstructive coronary disease amenable to surgical correction had been revascularized, possibly attenuating any putative negative effects of AF on myocardial blood flow and oxygen delivery. Further studies are needed to explore this hypothesis.
The second important finding in our study was that the relationship between AF and adverse outcomes in the longterm persisted across strata of age, sex, and procedure type. Although we included both CABG and valve surgery cohorts in our study in order to maximize the study's power, concerns about patient heterogeneity and the differential prognostic import of AF in these different patient sub-groups were addressed in sub-group analyses, in which AF was found to be equally detrimental in patients undergoing isolated CABG without surgically significant valvular pathology as in those undergoing corrective valve surgery.
Interestingly, there was a statistically significant effect modification according to the status of left ventricular systolic function, such that the magnitude of the detrimental effect of AF on clinical outcomes was reduced in patients with poor LVEF compared to those with preserved left ventricular function (Fig. 2) . Potential explanations are speculative; AF may be a marker for more severe disease in patients with normal LVEF undergoing CABG or valvular surgery. Or, alternatively, patients with depressed LVEF undergoing cardiac surgery have poor long-term outcomes at the outset, such that any independent contribution of AF to the prognosis of these patients may have been less significant. Further studies are also needed to elucidate this question.
Our results suggesting a negative impact of AF on late outcomes after cardiac surgery are consistent with some previous studies [4, 5] but refute others [6] . Two studies were recently published showing poorer long-term outcomes among CABG patients presenting with AF preoperatively. In one study, 650 patients were identified with pre-existing AF, but only 257 were included in the longitudinal analyses, which may have introduced some selection bias [4] . In addition, both rhythm status and cardiac events were determined by patient self-report, which may be subject to recall bias. In the study by Quader et al., 47,000 eligible post-cardiac surgery patients were identified but only 451 patients with electrocardiogram-documented AF were included yielding an overall prevalence of AF of 0.96% [5] . This inclusion criterion may have been too restrictive and may have missed patients with paroxysmal AF that may not be captured on cross-sectional electrocardiography. To our knowledge, our study is the largest to date that examined approximately 200 variables in a cohort of nearly 10,000 patients including 1105 patients with preoperative AF, using a nuanced clinical registry as well as validated health care utilization administrative databases for the acquisition of longitudinal, community-based data.
Study limitations
There are several limitations inherent in the study's design. First, there are no data on the chronicity of the AF prior to cardiac surgery. Patients were considered to have AF preoperatively if there was AF on a preoperative 12-lead electrocardiogram or there was a history of AF requiring treatment and/or hospitalization. Therefore, all AF subsets were included in the AF cohort, whether paroxysmal, persistent, or permanent forms of AF. However, we found that there was a 'dose-response' relationship between AF and clinical outcomes such that the sub-group of patients with preoperative AF discharged in AF had the greatest risk of death or hospital readmission (HR 1.75, p < 0.0001) compared to patients with preoperative AF discharged in sinus rhythm or patients without AF. These results lend credibility to the possibility that AF is not simply a surrogate marker for risk and there may be a true cause-effect relationship between AF and clinical outcomes post-cardiac surgery, although the retrospective nature of the study does not allow this interpretation of the data.
Another limitation is that we cannot comment on the management of patients after discharge with respect to outpatient rate and/or rhythm control and prophylaxis of thromboembolic events. For instance, differential patterns of utlilization of and adherence to antithrombotic therapy may partly explain our finding that the rate of cerebrovascular thromboembolic events among AF patients was more than twice that of patients without AF. However, during the time period of the study during which surgical ablative techniques for pre-existing AF were not commonplace at our institution, a universal, algorithm-based approach to patients with AF was in place consistent with published guidelines [19] . Briefly, medical or electrical cardioversion was attempted in all patients, whether the AF was preexisting or new-onset beginning in the postoperative period. If sinus rhythm could not be restored, patients were treated with beta-blockers or non-dihydropyridine calcium channel antagonists for ventricular rate control and were discharged on warfarin therapy after achieving an international normalized ratio of 2.0-3.0 or higher depending on the presence of a valvular prosthesis. Although oral anticoagulation therapy appears to be under-utilized among population-based AF cohorts, a recent study conducted in the same Canadian province from which our study participants originated showed that overall warfarin use was 68% in AF patients, and only 39% of the remaining untreated patients were candidates for anticoagulation according to recent peerreviewed consensus guidelines [20] . The relative merits of conversion to and maintenance of sinus rhythm in contrast to a strategy of ventricular rate control as sole therapy remain controversial [21] . However, there is evidence to suggest that the presence of sinus rhythm independently predicts better survival [22] . Recently, Bando et al. showed that conversion to sinus rhythm was associated with a diminished incidence of stroke in a cohort of patients with mechanical prosthetic valves that were already adequately anticoagulated for the valve [23] . A separate analysis of mechanical valve patients in our own study supports these results. In these patients, AF was still significantly predictive of the composite outcome of death or re-hospitalization, despite treatment with oral anticoagulation therapy for the valve.
Our data strongly suggest that AF is independently linked to worse outcomes among patients that have had their structural heart disease 'corrected' by surgical coronary revascularization and/or valve repair or replacement. Taken further, our findings appear to support the hypothesis that aggressive intraoperative attempts to restore sinus rhythm may be warranted and provide an opportunity to improve the longterm clinical outcomes of cardiac surgical patients. However, the retrospective and exploratory nature of these data cannot substantiate the assertion that routine ablation of AF at the time of surgery will improve cardiac surgical outcomes. Despite the current enthusiasm for concomitant ablation of AF during cardiac surgery, the patients who are most likely to benefit, the optimal energy source and lesion set, and definitions and reporting of success rates, have not been standardized and long-term results are lacking [24] . The optimal approach to patients with pre-existing AF presenting for cardiac surgery remains elusive and randomized, controlled clinical trials are needed in the setting of cardiac surgery.
